CHF 2,631.7 million
CHF 45.4 million
CHF 32.3 million
1,783 (1,477 full-time equivalents)
1) See section “Alternative performance measures” from page 86 onwards in the Annual report 2020 (full version)
In the year under review, the Services segment comprised logistics services for the Swiss healthcare market from Alloga (pre-wholesale), Galexis, Unione Farmaceutica Distribuzione and Pharmapool (wholesale), as well as Medifilm, which is active in drug blister packaging. These are complemented by services from HCI Solutions, which provides master data for the Swiss healthcare market and offers management software solutions for pharmacies. HCI Solutions also develops tools to securely manage, communicate and distribute sensitive health data and improve patient safety. As of 1 January 2021, Galenica has introduced a new organizational structure.
Net sales and operating result
The Services segment generated net sales of CHF 2,631.7 million in 2020, representing a strong increase of 7.8 % compared to the previous year. Services therefore clearly exceeded the growth of the overall market of +2.9 % (IQVIA, Pharmaceutical Market Switzerland, 2020). The adjusted1) operating result (EBIT), i.e. excluding the effects of the lease accounting standard IFRS 16, was increased by 1.6 % to CHF 45.4 million. However, adjusted1) return on sales (ROS) decreased slightly from 1.8 % to 1.7 %. Investments totalled CHF 32.3 million in the year under review (previous year: CHF 31.0 million), and were largely used for the modernisation and renovation of the Galexis distribution centre in Lausanne-Ecublens as well as for the gradual roll-out and implementation of the new enterprise resource planning (ERP) software at Alloga and Galexis.
- Net sales in million CHF
Galenica Group CHF 3,479.8 million
- EBIT adjusted1) in million CHF
Galenica Group CHF 168.6 million